Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / BIOTECHNOLOGY
-
Total 13F shares
-
1,236,332
-
Share change
-
-235,610
-
Total reported value
-
$66,128,491
-
Price per share
-
$53.51
-
Number of holders
-
77
-
Value change
-
-$12,699,172
-
Number of buys
-
18
-
Number of sells
-
36
Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) as of Q2 2019
As of 30 Jun 2019,
INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,236,332 shares.
The largest 10 holders included
CLS Investments, LLC, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, UBS Group AG, ROYAL BANK OF CANADA, BANK OF AMERICA CORP /DE/, LADENBURG THALMANN FINANCIAL SERVICES INC., PFG Advisors, LPL Financial LLC, and YHB Investment Advisors, Inc..
This page lists
77
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.